fluorodeoxyglucose f18 has been researched along with alpha-synuclein in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Farrer, MJ; Hattori, N; Imai, H; Inoue, Y; Ishii, K; Ishiwata, K; Kachergus, JM; Kitagawa, M; Kono, S; Mizoguchi, K; Mizuno, Y; Nishioka, K; Obi, T; Ross, OA; Takanashi, M | 1 |
| Aasly, JO; Armaly, J; Furay, AR; Hasegawa, K; Leverenz, JB; Shi, M; Sossi, V; Stoessl, AJ; Uitti, RJ; Wang, Y; Wszolek, ZK; Yokoyama, T; Zabetian, CP; Zhang, J | 1 |
| Arai, H; Fujishiro, H; Furukawa, Y; Higashi, S; Hino, H; Iseki, E; Kasanuki, K; Katsuse, O; Kosaka, K; Minegishi, M; Sato, K; Togo, T; Uchikado, H; Yamamoto, R | 1 |
| Baron, T; Billard, T; Bouillot, C; Chauveau, F; Lancelot, S; Levigoureux, E; Verchere, J; Verdurand, M; Zimmer, L | 1 |
| Caminiti, SP; Cappa, SF; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Sala, A; Tettamanti, M | 1 |
| Chaudhuri, KR; Niccolini, F; Pagano, G; Politis, M; Polychronis, S; Wilson, H; Yousaf, T | 1 |
| Chang, CJ; Chen, LF; Fuh, JL; Guo, WY; Hsu, TW; Huang, WS; Wang, DW; Wu, HM | 1 |
| Agnello, L; Blandino, V; Ciaccio, M; Colletti, T; Gambino, CM; Giglio, RV; Graziano, F; Guajana, F; La Bella, V; Lo Sasso, B; Maniscalco, L; Matranga, D; Piccoli, T | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and alpha-synuclein
| Article | Year |
|---|---|
Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Cholinergic Agents; Cognitive Dysfunction; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Positron-Emission Tomography | 2021 |
7 other study(ies) available for fluorodeoxyglucose f18 and alpha-synuclein
| Article | Year |
|---|---|
Expanding the clinical phenotype of SNCA duplication carriers.
Topics: Adult; Aged; alpha-Synuclein; Brain; Carbon Isotopes; Chromosome Mapping; Cocaine; Family Health; Female; Fluorodeoxyglucose F18; Gene Dosage; Gene Duplication; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Parkinson Disease; Phenotype; Positron-Emission Tomography; Raclopride; REM Sleep Behavior Disorder; Sensory Thresholds; Smell; Young Adult | 2009 |
DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function.
Topics: alpha-Synuclein; Biomarkers; Carbon Isotopes; Corpus Striatum; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Intracellular Signaling Peptides and Proteins; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Luria-Nebraska Neuropsychological Battery; Male; Methylphenidate; Norway; Oncogene Proteins; Parkinson Disease; Positron-Emission Tomography; Protein Deglycase DJ-1; Protein Serine-Threonine Kinases; Statistics as Topic; Tetrabenazine; United States | 2012 |
Neuropathological investigation of the hypometabolic regions on positron emission tomography with [18F] fluorodeoxyglucose in patients with dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Autopsy; Brain; Cell Count; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Lewy Body Disease; Male; Middle Aged; Neurofibrillary Tangles; Neurons; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins | 2012 |
Binding of the PET radiotracer [¹⁸F]BF227 does not reflect the presence of alpha-synuclein aggregates in transgenic mice.
Topics: alpha-Synuclein; Animals; Benzoxazoles; Brain Stem; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Positron-Emission Tomography; Radioligand Assay; Tauopathies; Thalamus; Thiazoles | 2014 |
Metabolic connectomics targeting brain pathology in dementia with Lewy bodies.
Topics: Acetylcholine; Aged; alpha-Synuclein; Brain; Connectome; Databases, Factual; Dopamine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Male; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2017 |
Urinary dysfunction in early de novo patients with Parkinson's disease.
Topics: alpha-Synuclein; Fluorodeoxyglucose F18; Humans; Kidney Diseases; Parkinson Disease; Tropanes | 2017 |
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Neurogranin; tau Proteins | 2022 |